News and Trends 27 Sep 2022
Angel Pharma announces approval of IND application for clinical trial of mupadolimab
Approval of an investigational new drug (IND) application for mupadolimab has been granted by the Center for Drug Evaluation (CDE) to initiate a phase 1/1b clinical trial in China. Angel…